Search Results - "CROSBY, Katherine"
-
1
Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non―Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion
Published in Clinical cancer research (15-08-2012)“…To deepen our understanding of mutant ROS1 expression, localization, and frequency in non-small cell lung cancer (NSCLC), we developed a highly specific and…”
Get full text
Journal Article -
2
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers
Published in Science translational medicine (08-02-2012)“…Most anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancers (NSCLCs) are highly responsive to treatment with ALK tyrosine kinase inhibitors…”
Get more information
Journal Article -
3
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Published in Nature medicine (01-12-2008)“…Somatic mutations that activate phosphoinositide 3-kinase (PI3K) have been identified in the p110-α catalytic subunit (encoded by PIK3CA). They are most…”
Get full text
Journal Article -
4
PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
Published in Clinical cancer research (15-03-2012)“…We sought to determine whether phosphoinositide 3-kinase (PI3K) pathway mutation or activation state and rapamycin-induced feedback loop activation of Akt is…”
Get full text
Journal Article -
5
Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody
Published in The American journal of surgical pathology (01-07-2009)“…NUT midline carcinoma (NMC) is a uniformly lethal malignancy that is defined by rearrangement of the nuclear protein in testis (NUT) gene on chromosome 15q14…”
Get full text
Journal Article -
6
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
Published in PloS one (06-01-2011)“…Cholangiocarcinoma, also known as bile duct cancer, is the second most common primary hepatic carcinoma with a median survival of less than 2 years. The…”
Get full text
Journal Article -
7
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
Published in Cancer cell (03-02-2009)“…mTOR complex 2 (mTORC2) contains the mammalian target of rapamycin (mTOR) kinase and the Rictor regulatory protein and phosphorylates Akt. Whether this…”
Get full text
Journal Article -
8
Genomic delineation and description of species and within-species lineages in the genus Pantoea
Published in Frontiers in microbiology (2023)“…As the name of the genus ("of all sorts and sources") suggests, this genus includes bacteria with a wide range of provenances, including plants, animals,…”
Get full text
Journal Article -
9
Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer
Published in Cancer research (Chicago, Ill.) (01-07-2012)“…Ovarian cancer is the leading cause of death from gynecologic cancer. Improvement in the clinical outcome of patients is likely to be achieved by the…”
Get full text
Journal Article -
10
Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer
Published in Clinical cancer research (01-05-2009)“…Purpose: Activating mutations within the tyrosine kinase domain of epidermal growth factor receptor (EGFR) are found in approximately 10% to 20% of…”
Get full text
Journal Article -
11
Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs
Published in RNA (Cambridge) (01-07-2008)“…Eukaryotic initiation factor (eIF) 4E, the mRNA 5'-cap-binding protein, mediates the association of eIF4F with the mRNA 5'-cap structure to stimulate…”
Get full text
Journal Article -
12
Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract
Published in Clinical cancer research (01-05-2007)“…Purpose: Development of prostate cancer prevention strategies is an important priority to overcome high incidence, morbidity, and mortality. Recently, we…”
Get full text
Journal Article -
13
Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma
Published in Journal of clinical oncology (10-02-2005)“…Activation of the platelet-derived growth factor (PDGF) and c-kit receptors has been proposed as important in mediating the growth of AIDS-related Kaposi's…”
Get full text
Journal Article -
14
Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine
Published in Neoplasia (New York, N.Y.) (01-11-2007)“…We recently showed that NexrutineR, a Phellodendron amurense bark extract, suppresses proliferation of prostate cancer cell lines and tumor development in the…”
Get full text
Journal Article -
15
Antibody-Based Profiling of the Phosphoinositide 3-Kinase Pathway in Clinical Prostate Cancer
Published in Clinical cancer research (15-12-2004)“…Purpose: As kinase inhibitors transition from the laboratory to patients, it is imperative to develop biomarkers that can be used in the clinic. The primary…”
Get full text
Journal Article -
16
Abstract 5689: Characterization of immune infiltrate and checkpoint protein expression patterns in murine syngeneic tumors via multiplex immunohistochemistry
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Murine syngeneic tumor models are increasingly utilized for preclinical immuno-oncology studies as immunotherapeutic strategies continue to make…”
Get full text
Journal Article -
17
Atlanto‐occipital subluxation in an adult Thoroughbred gelding
Published in Equine veterinary education (01-12-2023)“…Summary A 13‐year‐old gelding was referred to the University of Liverpool Equine Hospital for further investigation of ataxia and neck pain following a…”
Get full text
Journal Article -
18
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
Published in Cancer research (Chicago, Ill.) (15-03-2010)“…ErbB3 is a critical activator of phosphoinositide 3-kinase (PI3K) signaling in epidermal growth factor receptor (EGFR; ErbB1), ErbB2 [human epidermal growth…”
Get full text
Journal Article -
19
PD-1 blockade activates conventional CD4 T cells and the innate immune response during glioblastoma eradication
Published in The Journal of immunology (1950) (01-05-2018)“…Abstract Blockade of immune cell co-inhibitory receptor PD-1 using monoclonal antibodies enables anti-tumor immune responses in various solid tumors and…”
Get full text
Journal Article -
20
Abstract 290: Development and characterization of antibodies specific for the SS18-SSX fusion protein in synovial sarcoma
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Synovial sarcoma (SS) is a soft tissue cancer characterized by the fusion of the SS18 gene, which encodes for a subunit of the BAF ATP-dependent…”
Get full text
Journal Article